Dr. Gomez is investigating multi-modal therapeutic strategies to dually target immunosuppressive molecules of clinical significance in solid tumors. In line with these goals, she is also developing and testing a novel CAR T cell product in preclinical models of treatment-resistant pediatric brain tumors.
Targeting Apoptotic Viral Mimicry for The Treatment of Relapsed/Refractory Pediatric Brain Tumors
Momentum Fellow (2024-PRESENT)
Stephanie Gomez, PhD, Children’s National Hospital
Stephanie Gomez, PhD